Navigation Links
Tris Pharma Appoints New Vice President of Business Development
Date:11/15/2012

MONMOUTH JUNCTION, N.J., Nov. 15, 2012 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, announced the appointment of Jonathan Berlent as Vice President of Business Development.  He will lead Tris' product and technology partnering, and collaborate with branded pharmaceutical companies on their life cycle management opportunities. 

"As Tris scales up its effort to address the growing unmet need in the industry for liquid extended release technology, Jonathan will lead business development efforts and be our point person with branded pharmaceutical companies," said Ketan Mehta, President and CEO of Tris Pharma.  "With Jonathan leading business development, Peter Ciano will focus on strategy and corporate development activities including acquisitions."

"Tris is a pioneer in commercializing unique, sustained release formulations such as oral liquid suspensions, orally disintegrating tablets and chewable tablets that do not require patients to swallow a pill," said Berlent. "I am truly excited to be part of the Tris management team and look forward to leading business development efforts."

Jonathan brings to Tris a combination of pharmaceutical and securities industry experience.  For the past nine years, he has held various senior leadership positions in the pharmaceutical industry.  Most recently, he was President of Granules USA, Inc., where he led its North American operations and successfully launched a finished dosage business platform working with such companies as Pfizer, Novartis, McNeil Consumer Health Janssen, GlaxoSmithKline, Par and Perrigo.  He began his career in the capital markets at Bank of America.  He is an alumnus of the University of Michigan and has an MBA from NYU Stern School of Business, where he majored in finance and management.

About Tris Pharma:

Tris Pharma is a specialty pharmaceutical c
'/>"/>

SOURCE Tris Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 The Board of Directors of ... provider of clinical trial imaging solutions, announced today that ... president and chief executive officer, effective immediately.  Mr. Converse ... and has held the positions of interim president and ... Dr. Charles E. Phelps , Ph.D., chairman of ...
(Date:7/23/2014)... 23, 2014 NOT FOR RELEASE, ... INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO ... REGULATIONS OF SUCH JURISDICTION. AbbVie (NYSE: ... Friday, July 25, 2014, before the market opens. ... call at 8 a.m. Central time (9 a.m. Eastern). It ...
(Date:7/23/2014)... 23, 2014 /PRNewswire-iReach/ -- Use of Risk Evaluation and ... delay generic market entry results in $5.4 billion in ... and analysis by economic consulting firm Matrix ... http://photos.prnewswire.com/prnh/20140723/129680 Required by the Food and ... REMS programs are intended to improve drug safety by ...
Breaking Medicine Technology:Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 2Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 3Eric T. Converse Named President And Chief Executive Officer Of VirtualScopics, Inc. 4AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6New Analysis Finds $5.4 Billion In Annual Lost Savings From Strategies Geared Toward Delaying Generic Drug Entry 2
... Reactions to House Dust Mite in... -- OXFORD, England, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... Update for the Third Quarter 2010 -- AMSTERDAM, November 18, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
Cached Medicine Technology:Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 2Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 3Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 4Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 5Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 6Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 7Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine 8AMT Provides Business Update for the Third Quarter 2010 2AMT Provides Business Update for the Third Quarter 2010 3AMT Provides Business Update for the Third Quarter 2010 4AMT Provides Business Update for the Third Quarter 2010 5AMT Provides Business Update for the Third Quarter 2010 6AMT Provides Business Update for the Third Quarter 2010 7AMT Provides Business Update for the Third Quarter 2010 8
(Date:7/23/2014)... Celebrating a decade of philanthropy in 2014, ... awarding of $1,070,000 in grants to 20 New Jersey ... the Foundation’s 1,000th grant. , “The Horizon Foundation for ... supporting community-based organizations that are working to improve public ... Garden State,” said Robert A. Marino, Horizon Blue Cross ...
(Date:7/23/2014)... growing body of research suggesting a safe and ... postmenopausal breast cancer, with fewer detrimental side effects ... therapies. The study will be published in final ... Biology and Endocrinology . , Breast cancer is ... the United States. Approximately 70% of breast cancers ...
(Date:7/23/2014)... 23, 2014 Global Cardio Care, Inc., ... External Counterpulsation (EECP), is celebrating the 100th birthday ... at the health center. , Weber has been ... receiving ongoing EECP therapy since 1999, he no longer ... CEO of Global Cardio Care, introduced the Sara ...
(Date:7/23/2014)... Memphis, Tenn. (PRWEB) July 23, 2014 The voice ... the telephone call that brought the news he was infected with ... stopped for a little bit and next thing you know I ... a baby.” , Yet the message was hopeful when the recording ... the end of you . . . because it is ...
(Date:7/23/2014)... News) -- For patients infected with both HIV and ... both viruses, a small study suggests. Researchers said ... for people with the two diseases. "The ... an important role in the management of individuals with ... Kenneth Sherman, a professor of medicine at the University ...
Breaking Medicine News(10 mins):Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 2Health News:HIV clinic-based audio project emphasizes the power of patient voices 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2
... and reliable information are essential for women who find ... live in rural areas where health services are patchy ... in the latest issue of the Journal of Advanced ... provider in Nova Scotia, a predominantly rural Canadian province ...
... rarely detected before it has grown large enough to impair ... disease to fight, especially since chemotherapy is not very effective. ... Faingold may open the door for very promising new treatment ... the cover of the February 2008 issue of Clinical Cancer ...
... Feb. 19 Viola Startzman, M.D. of,Wooster, Ohio is ... Award for,Excellence in Volunteerism. Presented by the American Medical ... physicians for,commitment to volunteer medical care to those without ... presents the award in association with the,Pfizer Medical Humanities ...
... CHICAGO, Feb. 19 The American Medical,Association ... the highest ideals of medical service in ... physicians will be honored during the,sixth annual ... 31, 2008,preceding the American Medical Association,s National ...
... LONDON, February 19 NHS Choices ( http://www.nhs.uk ... a new interactive tool aimed,to help people assess ... limits for sensible drinking., Based on NHS ... enables users,to find out in seconds whether they ...
... Delivered to German Government in January, BETHESDA, ... of global health economics has just delivered to ... of drug policy produced in,Europe in more than ... The 70-page report, commissioned last year by ...
Cached Medicine News:Health News:Menopausal women need better health care and community support in rural areas 2Health News:Menopausal women need better health care and community support in rural areas 3Health News:HSP90: New point of view on melanoma of the eye, at the MUHC 2Health News:AMA Foundation Honors Wooster, Ohio Physician for Volunteerism 2Health News:AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards 2Health News:AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards 3Health News:AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards 4Health News:AMA Foundation Honors Compassionate Physicians With Excellence in Medicine Awards 5Health News:United BioSource Scientist Leads Development of New Guidelines for Drug Reimbursement by German Government 2
Straight Shafts with Serrated 5mm Platform with 0.2 tips; overall length 105mm In Titanium...
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
45 Degree Angle With 0.3, 12 Teeth with 5mm Tying Platform; In Titanium....
0.3mm tips; 9.5mm from tips to cross action; in Titanium....
Medicine Products: